Silence Buys Into Arrowhead Pharmaceuticals

16.01.2017 - UK-based Silence Therapeutics has acquired an 8.4% equity stake in US biotech group Arrowhead Pharmaceuticals to potentially advance progress in novel RNA therapeutics. Silence...